References
- Whittaker VP. How the cholinesterases got their modern names. Chem Biol Interact 2010;187:23-6.
- Darvesh S, Hopkins DA, Geula C. Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 2003;4:131-8.
- Alles GA, Hawes RC. Cholinesterases in the blood of man. J Biol Chem 1940;133:375-90.
- Enzyme Nomenclature, Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes. San Diego (CA): Academic Press Inc.; 1992.
- Sagane Y, Nakagawa T, Yamamoto K, Michikawa S, Oguri S, Momonoki YS. Molecular characterization of maize acetylcholinesterase: a novel enzyme family in the plant kingdom. Plant Physiol 2005;138:1359-71.
- Taylor P, Radić Z. The cholinesterases: from genes to proteins. Annu Rev Pharmacol Toxicol 1994;34:281-320.
- Stryer L. Biokemija. Zagreb: Školska knjiga; 1991.
- Quin DM. Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transitions states. Chem Rev 1987;78:955-79.
- Soreq H, Seidman S. Acetylcholinesterase - new roles for and old actor. Nat Rev Neurosci 2001;2:294-302.
- Kaplan D, Ordentlich A, Barak D, Ariel N, Kronman C, Velan B, Shafferman A. Does "butyrylization" of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active centre gorge generate an enzyme mimic of butyrylcholonesterase? Biochemistry 2001;40:7433-45.
- Chatonnet A, Lockridge O. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem J 1989;260:625-34.
- Lockridge O, Masson P. Pesticides and susceptible populations: people with butyrylkolinesterase genetic variants may be at risk. Neurotoxicology 2000;21:113-26.
- Çokuğras NA. Butyrylcholinesterase: structure and physiological importance. Turk J Biochem 2003;28:54-61.
- Mesulam MM, Guillozet A, Shaw P, Levey A, Duysen EG, Lockridge O. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 2002;110:627-39.
- Saez-Valero J, Small DH. Alterd glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease. Brain Res 2001;889:247-50.
- Fisher MA. Use of cholinesterase inhibitors in the theraphy of myasthenia gravis. U: Giacobini E, urednik. Cholinesterasee and cholinesterase inhibitors. London: Martin Dunitz Ltd.; 2000. str. 249-62.
- Giacobini E. Butyrylcholinesterase: its role in brain function. U: Giacobini E, urednik. Butyrylcholinesterase, its function and inhibitors. London: Martin Dunitz Ltd.; 2003. str. 1-20.
- Poewe W, Gauthier S, Aarsland D, Leverenz JB, Barone P, Weintraub D, Tolosa E, Dubois B. Diagnosis and menagment of Parkinson's disease dementia. Int J Clin Pract 2008;62:1581-7.
- Liederer BM, Borchardt RT. Enzymes involved in the bioconversion of ester-based prodrugs. J Pharm Sci 2006;95:1177-95.
- Meshorer E, Soreq H. Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends Neurosci 2006;29:216-24.
- Greenfield SA, Zimmermann M, Bond CE. Non-hydrolytic functions of acetylcholinesterase. The significance of Cterminal peptides. FEBS J 2008;275:604-11.
- Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F. Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J Biol Chem 2003;278:41141-7.
- Silman I, Sussman J. Structural studies on acetylcholinesterase. U: Giacobini E, urednik. Cholinesterases and cholinesterase inhibitors. London: Martin Dunitz Ltd.; 2000. str. 9-26.
- Harel M, Sussman JL, Krejci E, Bon S, Chanal P, Massoulie J, Silman I. Conversion of acetylcholinesterase to butyrylcholinesterase: Modeling and mutagenesis. Proc Natl Acad Sci USA 1992;89:10827-31.
- Hasin Y, Avidan N, Bercovich D, Korczyn AD, Silman I, Beckmann JS, Sussman JL. Analysis of genetic polymorphisms in acetylcholinesterase as reflected in different populations. Curr Alzheimer Res 2005;2:207-18.
- Gennari K, Brunner J, Brodbeck U. Tetrameric detergentsoluble acetylcholinesterase from human caudate nucleus: subunit composition and number of active sites. J Neurochem 1987;49:12-8.
- Massoulié J, Bon S. The molecular form of cholinesterase and acetylcholinesterase in vertebrates. Ann Rev Neurosci 1982;5:57-106.
- Massoulie J, Bonn S, Perrier N, Falasca C. The C-terminal peptides of acetylcholinesterase: Cellular trafficing, oligomerization and functional ancoring. Chem Biol Interact 2005;157-158:3-14.
- Thiermann H, Szinicz L, Eyer P, Zilker T, Worek F. Correlation between red blood cell acetylcholinesterase activity and neuromuscular transmission in organophosphate poisoning. Chem Biol Interact 2005;157-158:345-7.
- Thiermann H, Szinicz L, Eyer P, Felgenhauer N, Zilker T, Worek F. Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning. Toxicology 2007;233:145-54.
- Reiner E, Šinko G, Škrinjarić-Špoljar M, Simeon-Rudolf V. Comparison of protocols for measuring activities of human blood cholinesterases by the Ellman method. Arh Hig Rada Toksikol 2000;51:13-8.
- Thiermann H, Mast U, Klimmek R, Eyer P, Hibler A, Pfab R, Flegenhauer N, Zilker T. Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients. Hum Exp Toxicol 1997;16:473-80.
- Velan B, Kronman C, Ordentlich A, Flashner Y, Leitner M, Cohen S, Shafferman A. N-glycosylation of human acetylcholinesterase: effects on activity, stability and biosynthesis. Biochem J 1993;296:649-56.
- Lockridge O, Bartels CF, Vaughan TA, Wong CK, Norton SE, Johnson LL. Complete amino acid sequence of human serum cholinesterase. J. Biol Chem 1987;262:549-57.
- Jensen FS, Schwartz M, Viby-Mogensen J. Identification of human plasma cholinesterase variants using molecular biological techniques. Acta Anaesthesiol Scand 1995;39:142-9.
- La Du BN, Bartels CF, Nogueira CP, Hajra A, Lightstone H, Van der Spek A, Lockridge O. Phenotypic and molecular biological analysis of human butyrylcholinesterase variants. Clin Biochem 1990;23:423-31.
- Primo-Parmo SL, Bartels CF, Wiersema B, Van der Speck AFL, Innis JW, La Du BN. Characterisation of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene. Am J Hum Genet 1996;58:52-64.
- Simeon-Rudolf V, Evans RT. Interlaboratory study into proficiency of attribution of human serum butyrylcholinesterase phenotypes: Reference values of activities and inhibitor numbers. Acta Pharm 2001;51:289-96.
- Kovarik Z, Simeon-Rudolf V. An improvement in segregation of human butyrylcholinesterase phenotypes having the fluoride-resistant variants. Arh Hig Rada Toksikol 2003;54:239-44.
- Gätke MR, Bundgaard JR, Viby-Mogensen J. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia. Pharmacogenet Genom 2007;17:995-9.
- Podoly E, Shalev DE, Shenhar-Tsarfaty S, Bennett ER, Assayag EB, Wilgus H, Livnah O, Soreq H. The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology. J Biol Chem 2009;284:17170-9.
- Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 1991;253:872-9.
- Kryger G, Harel M, Giles K, Toker L, Velan B, Lazar A, Kronman C, Barak D, Ariel N, Shafferman A, Silman I, Sussman JL. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta Crystallogr Sect D 2000;56:1385-94.
- Cygler M, Schrag JD, Sussman JL, Harel M, Silman I, Gentry MK, Doctor BP. Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases, and related proteins. Prot Sci 1993;2:366-82.
- Taylor P, Radic Z, Hosea NA, Camp S, Marchot P, Berman HA. Structural bases for the specificity of cholinesterase catalysis and inhibition. Toxicol Lett 1995;82-83:453-8.
- Saxena A, Redman AMG, Jiang X, Lockridge O, Doctor BP. Differences in active-site gorge dimensions of cholinesterase revealed by binding of inhibitors to human butyrylcholinesterase. Chem Biol Interact 1999;119-120:61-9.
- Saxena A, Ashani Y, Raveh L, Stevenson D, Patel T, Doctor BP. Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases. Mol Pharmacol 1998;53:112-22.
- Nachon F, Nicolet Y, Viguiea N, Masson P, Fontecilla-Camps JC, Lockridge O. Engineering of a monomeric and lowglycosylated form of human butyrylcholinesterase: Expression, purification, characterization and crystallization. Eur J Biochem 2002;269:630-7.
- Kolarich D, Weber A, Pabst M, Stadlmann J, Teschner W, Ehrlich H, Schwarz H-P, Altmann F. Glycoproteomic characterization of butyrylcholinesterase from human plasma. Proteomics 2008;8:254-63.
- Nicolet Y, Lockridge O, Masson P, Fontecellia-Camps JC, Nachon F. Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J Biol Chem 2003;278:41141-7.
- Bourne Y, Taylor P, Bougis PB, Marchot P. Crystal structure of mouse acetylcholinesterase. J Biol Chem 1999;274:2963-70.
- Nachon F, Masson P, Nicolet Y, Lockridge O, Fontecilla-Camps JC. Comparison of structures of butyrylcholinesterase and acetylcholinesterase. U: Giacobini E, urednik. Butyrylcholinesterase, its function and inhibitors. London: Martin Dunitz Ltd.; 2003. str. 39.
- Ordentlich A, Kronman C, Barak D, Stein D, Ariel N, Marcus D, Velan B, Shafferman A. Engineering resistance to aging of phosphylated human acetylcholinesterase - Role of hydrogen bond network in the active center. FEBS Lett 1993;334:215-20.
- Shafferman A, Ordentlich A, Barak D, Stein D, Ariel N, Velan B. Aging of phosphylated human acetylcholinesterase: catalytic processes mediated by aromatic and polar residues of the active centre. Bichem J 1996;318:833-40.
- Ordentlich A, Barak D, Kronman C, Flashner Y, Leitner M, Segall Y, Ariel N, Cohen S, Velan B, Shafferman A. Dissection of the human acetylcholinesterase active centre determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. J Biol Chem 1993;268:17083-95.
- Radić Z, Pickering NA, Vellom DC, Camp S, Taylor P. Three distinct domains in the cholinesterase molecule confer selectivity for acetylcholinesterase and butyrylcholinesterase inhibitors. Biochemistry 1993;32:12074-84.
- Goličnik M, Šinko G, Simeon-Rudolf V, Grubič Z, Stojan J. Kinetic model of ethropropazine interaction with horse serum butyrylcholinesterase and its docking into the active site. Arch Biochem Biophys 2002;398:23-31.
- Harel M, Sussman JL, Krejci E, Bon S, Chanal P, Massoulié P. Conversion of acetylcholinesterase to butyrylcholinesterase, modelling and mutagenesis. Proc Natl Acad Sci USA 1992;89:10827-31.
- Radić Z, Reiner E, Taylor P. Role of the peripheral anionic site on acetylcholinesterase: inhibition by substrates and coumarin derivatives. Mol Pharmacol 1991;39:98-104.
- McGuire MC, Nogueira CP, Bartels CF, Lightstone H, Hajra A, Van der Speck AF, Lockridge O, La Du BN. Identification of the structural mutation responsible for the dibucaineresistant (atypical) variant form of human serum butyrylcholinesterase. Proc Natl Acad Sci USA 1989;86:953-7.
- Masson P, Froment M-T, Bartels CF, Lockridge O. Asp70 in the peripheral anionic site of human butyrylcholinesterase. Eur J Biochem 1996;235:36-48.
- Chambers J, Patricia EL. Organophosphates: Chemistry, Fate and Effects. New York (NY): Academic Press, Inc.; 1992.
- Jokanović M, Stojiljković MP. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning. Eur J Pharmacol 2006;553:10-7.
- Taylor P, Kovarik Z, Reiner E, Radić Z. Acetylcholinesterase: converting a vulnerable target to a template for antidotes and detection of inhibitor exposure. Toxicology 2007;233:70-8.
- Lenz DE, Yeung D, Smith JR, Sweeney RE, Lumley LA, Cerasoli DM. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: A mini review. Toxicology 2007;233:31-9.
- Maxwell DM, Saxena A, Gordon RK, Doctor BP. Improvements in scavenger protection against organophosphorus agents by modification of cholinesterases. Chem Biol Interact 1999;119-120:419-28.
- Holmstedt B. Cholinesterase inhibitors: an introduction. U: Giacobini E, urednik. Cholinesterases and cholinesterase inhibitors. London: Martin Dunitz Ltd.; 2000. str. 1-8.
- Giacobini E. Cholinesterase inhibitors: from the Calabar bean to the Alzheimer therapy. U: Giacobini E. urednik. Cholinesterases and cholinesterase inhibitors. London: Martin Dunitz Ltd.; 2000. str. 181-227.
- Katalinić M, Rusak G, Domaćinović Barović J, Šinko G, Jelić D, Antolović R, Kovarik Z. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase. Eur J Med Chem 2010;45:186-92.
- Reiner E, Radić Z. Mechanism of action of cholinesterase inhibitor. U: Giacobini E. urednik. Cholinesterases and cholinesterase inhibitors. London: Martin Dunitz Ltd.; 2000. str. 103-20.
- Ripoll DR, Faerman CH, Sussman JL. An electrostatic mechanism for substrate guidance down the aromatic gorge of acetylcholinesterase. Proc Natl Acad Sci USA 1993;90:5128-32.
- Yoshida A, Motulsky AG. A pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity. Am J Hum Genet 1969;21:486-98.
- Lewis WG, Green LG, Grynszpan F, Radić Z, Carlier PR, Taylor P, Finn MG, Sharpless KB. Click chemistry in situ: Acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of bilding blocks. Angew Chem Int Ed 2002;41:1053-7.
- Krasiński A, Radić Z, Manetsch R, Raushel J, Taylor P, Sharpless KB, Kolb HC. In situ selection of lead compounds by click chemistry: target-guided optimization of acetylcholinesterase inhibitors. J Am Chem Soc 2005;127:6686-92.
- Brufani M, Filocamo L. Rational design of cholinesterase inhibitors. U: Giacobini E. urednik. Cholinesterases and cholinesterase inhibitors. London: Martin Dunitz Ltd.; 2000. str. 27-46.
- Bosak A. Organofosforni spojevi: klasifikacija i reakcije s enzimima. Arh Hig Rada Toksikol 2006;57:445-57.
- Worek F, Thiermann H, Szinicz L, Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem Pharmacol 2004;68:2237-48.
- Tunek A, Svensson LA. Bambuterol, a carbamate ester prodrug of terbutalin, as inhibitor of cholinesterase in human blood. Drug Metab Dispos 1988;16:759-64.
- Kovarik Z, Simeon-Rudolf V. Interaction of human butyrylcholinesterase variants with bambuterol and terbutaline. J Enzym Inhib Med Chem 2004;19:113-7.
- Sitar DS. Clinical pharmacokinetics of bambuterol. Clin Pharmacokinet 1996;31:246-56.
- Nyberg L, Rosenborg J, Weibull E, Jönsson S, Kennedy BM, Nilsson M. Pharmacokinetics of bambuterol in healthy subjetcs. Br J Clin Pharmacol 1998;45:471-8.
- Eto M. Organic and biological chemistry. U: Zweig G, urednik. The organophosphorus pesticides. Cleveland (OH): CRC Press Inc.; 1976. str. 142.
- Pope C, Karanth S, Liu J. Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of common mechanism of action. Environ Toxicol Pharmacol 2005;19:433-6.
- Costa LG. Current issue in organophosphate toxicology. Clin Chim Acta 2006;366:1-13.
- Popis aktivnih tvari dopuštenih za uporabu u sredstvima za zaštitu bilja u Republici Hrvatskoj. Narodne novine 80/2008.
- Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev 2003;22:165-90.
- Wiener SW, Hoffman RS. Nerve agents: A comprehensive review. J Intensive Care Med 2004;19:22-37.
- Delfino RT, Ribeiro TS, Figueroa-Villar JD. Organophosphorus compounds as chemical warfare agents: a review. J Braz Chem Soc 2009;20:407-28.
- Kovarik Z, Radić Z, Grgas B, Škrinjarić-Špoljar M, Reiner E, Simeon-Rudolf V. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline. BBA - Protein Struct Mol Enzymol 1999;1433:261-71.
- Reiner E, Bosak A, Simeon-Rudolf V. Activity of cholinesterases in human whole blood measured with acetylthiocholine as substrate and ethopropazine as selective inhibitor of plasma butyrylcholinesterase. Arh Hig Rada Toksikol 2004;55:1-4.
- Kovarik Z, Simeon-Rudolf V. An improvement in segregation of human butyrylcholinesterase phenotypes having the fluoride-resistant variants. Arh Hig Rada Toksikol 2003;54:239-44.
- Faber K. Biotransformations in Organic Chemistry: A Textbook. 5. izd. Berlin Heidelberg: Springer-Verlag; 2004.
- Shafferman A, Barak D, Stein D, Kronman C, Velan B, Greig NG, Ordentlich A. Flexibility versus "rigidity" of the functional architecture of AChE active center. Chem Biol Interact 2008;175:166-72.
- Barak D, Ordentlich A, Stein D, Yu Q-S, Greig NH, Shafferman A. Accomodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions. Biochem J 2009;417:213-22.
- Šinko G, Radić Z, Taylor P, Simeon-Rudolf V, Reiner E. Kinetics of interaction of ethopropazine enantiomers with butyrylcholinesterase and acetylcholinesterase. U: Fisher A, Silman I, Soreq H, Anglister L, Michaelson DM, urednici. Proceedings of the XIth ISCM, Cholinergic Mechanisms: Function and Dysfunction; London: & Taylor Francis; 2004. str. 705-6.
- Gazić I, Bosak A, Šinko G, Vinković V, Kovarik. Preparative HPLC separation of bambuterol enantiomers and stereoselective inhibition of human cholinesterases. Anal Bioanal Chem 2006;385:1513-9.
- Bosak A, Gazić I, Vinković V. Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers. Chem Biol Interact 2008;175:192-5.
- Taylor P, Hosea NA, Tsigelny I, Radić Z, Berman HA. Determining ligand orientation and transphosphonylation mechanisms on acetylcholinesterase by Rp, Sp enantiomer selectivity and site-specific mutagenesis. Enantiomer 1997;2:249-60.
- Hosea NA, Berman HA, Taylor P. Specificity and orientations of trigonal carboxyl esters and tetrahedral alkylphosphonyl esters in cholinesterases. Biochemistry 1995;34:11528-36.
- Bosak A, Primožič I, Oršulić M, Tomić S, Simeon-Rudolf V. Enantiomers of quinuclidin-3-ol derivatives: Resolution and interactions with human cholinesterases. Croat Chem Acta 2005;78:121-8.
- šinko G. Enzimske i proteinske metode u pripravi enantiomerno čistih kiralnih spojeva i svojstva nekih biološki aktivnih enantiomera. Arh Hig Rada Toksikol 2005;56:351-61.
- RCSB Protein Data Bank [pristup 26. studenoga 2010.]. Dostupno na http://www.pdb.org
- ESTHER Database [pristup 26. studenoga 2010.]. Dostupno na http://bioweb.ensam.inra.fr/esther
- Ekström FJ, Astot C, Pang Y-P. Novel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotes. Clin Pharmacol Ther 2007;82:282-93.
- Ekström FJ, Pang Y-P, Boman M, Artursson E, Akfur C, Börjegren S. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates. Biochem Pharmacol 2006;72:597-607.
- Lushington GH, Guo J-X, Hurley MM. Acetylcholinesterase reprised: Molecular modeling with the whole toolkit. Front Med Chem 2010;5:423-56.
- Bartolucci C, Perola E, Cellai L, Brufani M, Lamba D. "Back door" opening implied by the crystal structure of a carbamoylated acetylcholinesterase. Biochemistry 1999;38:5714-9.
- Alisaraie L, Fels G. Molecular docking study on the "back door" hypothesis for product clearance in acetylcholinesterase. J Mol Model 2006;12:348-54.
- Kovarik Z, Radić Z, Taylor P. Site-directed mutagenesis of acetylcholinseterase - a tool for studying structure/function relationship. Period biol 2004;106:289-94.
- Kovarik Z, Radić Z, Berman HA, Simeon-Rudolf V, Reiner E, Taylor P. Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates. Biochemistry 2004;43:3222-9.
- Kovarik Z, Radić Z, Berman HA, Taylor P. Mutation of acetylcholinesterase to enhance oxime-assisted catalytic turnover of methylphosphonates. Toxicology 2007;233:79-84.
- Saxena A, Maxwell DM, Quinn DM, Radić Z, Taylor P, Doctor BP. Mutant acetylcholinesterases as potential detoxification agents for organophosphate poisoning. Biochem Pharmacol 1997;54:269-74.
- Gibney G, Camp S, Dionne M, MacPhee-Quigley K, Taylor P. Mutagenesis of essential functional residues in acetylcholinesterase. Proc Nati Acad Sci USA 1990;87:7546-50.
- Bosak A, Gazić I, Vinković V, Kovarik Z. Aminoacids residues involved in stereoselective inhibition of cholinesterases with bambuterol. Arch Biochem Biophys 2008;471:72-6.
- Kovarik Z, Radić Z, Berman HA, Simeon-Rudolf V, Reiner V, Taylor P. Acetylcholinesterase active center and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates. Biochem J 2003;373:33-40.
- Masson P, Nachon F, Broomfield CA, Lenz DE, Verdier L, Schopfer LM, Lockridge O. A collaborative endeavour to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters. Chem Biol Interact 2008;175:273-80.
- Kovarik Z, Lucić Vrdoljak A, Berend S, Katalinić M, Kuča K, Musilek K, Radić B. Evaluation of oxime K203 as antidote in tabun poisoning. Arh Hig Rada Toksikol 2009;60:19-26.
- Stojiljković MP, Jokanović M. Pyridinium oximes: rationale for their selection as causal antidotes against organophosphate poisonings and current solutions for auto-injectors. Arh Hig Rada Toksikol 2006;57:435-43.
- Kalow W, Genest K. A method for the detection of atypical forms of human serum cholinesterase: Determination of dibucaine numbers. Can J Biochem Physiol 1957;35:339-46.
- Harris H, Whittaker M. diferential inhibition of human serum cholinesterase with fluoride: Recognition of new phenotypes. Nature 1961;191:3898-904.
- Nogueira CP, Bartels CF, McGuire MC, Adkins S, Lubrano T, Rubinstein HM, Lightstone H, Van der Speck AF, Lockridge O, La Du BN. Identification of two different point mutations associated with the fluoride-resistant phenotype for human butyrylcholinesterase. Am J Hum Gen 1992;51:821-8.
- Rubinstein HM, Dietz AA, Lubrano T. E1K, another quantitative variant at cholinesterase locus1. J Mol Genet 1978;15:27-9.
- Bartels CF, Jensen FS, Lockridge O, Van der Speck AFL, Rubinstein HM, Lubrano T, La Du BN. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 1992;50:1086-103.
- Rubinstein HM, Dietz AA, Lubrano T, Garry PJ. E1J, a quantitative variant at cholinesterase locus1: Immunological evidence. J Med Genet 1976;13:43-5.
- Bartels CF, James K, La Du BN. DNA mutation associated with the human butyrylcholinesterase J-variant. Am J Hum Genet 1992;50:1104-14.
- Whittaker M, Britten JJ. Plasma cholinesterase variants. Family studies of the E1K gene. Hum Hered 1985;35:364-8.
- Jensen FS, Bartels CF, La Du BN. Cholinesterases: structure, function, genetics, and cell biology. U: Massoulie J, Bacon F, Bernard E, Chatonnet A, Doctor BP, Quinn DM, urednici. Washington (DC): American Chemical Society; 1992.
- Maekawa M, Sudo K, Kanno T, Kotani K, Dey DC, Ishikawa J, Izumi M, Etoh K. Genetic basis of the silent phenotype of serum butyrylcholinesterase in three compound heterozygotes. Clin Chim Acta 1995;235:41-57.
- Harris H, Whittaker M. Diferential inhibition of human serum cholinesterase with fluoride: recognition of new phenotypes. Nature 1986;191:3898-904.